We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




High Speed Slide Scanner Introduced for Digital Pathology

By LabMedica International staff writers
Posted on 20 May 2010
Print article
A high-speed slide scanner is used for digital pathology applications such as image analysis, telepathology, remote microscopy, and education.

The Iscan Coreo Au allows walkaway scanning of up to 160 slides and includes an automated turret with multiple objectives, volume scan (z-stacked) images with multiple planes, and Iscan Coreo Au Live, an application supporting remote microscopy and collaboration.

BioImagene (Sunnyvale, CA, USA) unveiled the Iscan Coreo Au together with the latest version of Virtuoso software at the United States and Canadian Academy of Pathology (USCAP) annual meeting, which was held from March 22-24, 2010, in Washington D.C. (USA).

Virtuoso uses web technology to transform the viewing experience for pathologists. It offers users companion algorithms for a complete breast, prostate, and colon panel. Some of the features in Virtuoso include work-list management, real-time collaboration between users, and a fast viewing experience.

Dr. Ajit Singh, CEO of BioImagene said, "Speed is the single most important factor that will accelerate adoption of digital pathology. The launch of Iscan Coreo Au and Virtuoso is a key milestone for the industry: it unequivocally takes the speed of scanning and viewing to benchmark levels."

BioImagene focuses on end-to-end digital pathology solutions, and its suite of products also includes the innovative iSlide input device and the Crescendo digital pathology workstation. The company is a leading provider of innovative and scalable digital pathology solutions for diagnostics. Its product line includes a unique image viewing input device called the iSlide, and a high-performance pathology workstation called Crescendo. BioImagene is also the platinum sponsor of PathXchange, a vendor neutral, not for profit website for the pathology community.

Related Links:
BioImagene


Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
HbA1c Test
HbA1c Rapid Test
New
Alpha-Fetoprotein Reagent
AFP Reagent Kit

Print article

Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.